Tag: adagio medical
Adagio completes first procedures in pivotal study of VT cryoablation system
Adagio Medical has announced the completion of the first procedures in the FULCRUM-VT US Food and Drug Administration (FDA) pivotal investigational device exemption (IDE)...
Adagio and ARYA IV combine to form new company focused on...
Adagio Medical has announced the completion of its business combination with ARYA Sciences Acquisition Corp IV—a special purpose acquisition company sponsored by an affiliate...
Adagio Medical’s ultra-low temperature cryoablation system gains CE mark for monomorphic...
Adagio Medical has announced CE mark approval of its ultra-low temperature cryoablation (ULTC) system for the treatment of monomorphic ventricular tachycardia.
The system consists of...
First patients treated using Adagio Medical’s pulsed field cryoablation system
Adagio Medical has announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF).
The cases were performed at Medicover Hospital,...
Adagio Medical receives CE mark for iCLAS ablation system
Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...
Adagio Medical treats first atrial fibrillation patients using new One Shot+...
Adagio Medical, the developer of the iCLAS technology—the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias—announces that the...
First three patients enrolled in Adagio Medical CryoCure study
The first three persistent atrial fibrillation patients have been treated using Adagio’s cryolinear ablation technology. This follows the successful treatment of over 25 arrhythmia...